Serum Cystatin C in Elderly Cardiac Surgery Patients Anne Ristikankare, MD, Reino Pöyhiä, MD, PhD, Anne Kuitunen, MD, PhD, Markus Skrifvars, MD, PhD, Pekka Hämmäinen, MD, PhD, Markku Salmenperä, MD, PhD, Raili Suojaranta-Ylinen, MD, PhD The Annals of Thoracic Surgery Volume 89, Issue 3, Pages 689-694 (March 2010) DOI: 10.1016/j.athoracsur.2009.11.018 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 The proportional change of creatinine (•) and cystatin C (■) after cardiac surgery in patients with acute kidney injury as defined by the risk, injury, failure, loss, and end-stage kidney disease criteria. The change is relative to the preoperative creatinine or cystatin C value, respectively. The Annals of Thoracic Surgery 2010 89, 689-694DOI: (10.1016/j.athoracsur.2009.11.018) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Receiver operating characteristic curves for the absolute values of creatinine (light grey line) and cystatin C (dashed line) on postoperative days 1 (A) and 2 (B). The Annals of Thoracic Surgery 2010 89, 689-694DOI: (10.1016/j.athoracsur.2009.11.018) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions